Product NDC: | 0069-4495 |
Proprietary Name: | Ifosfamide |
Non Proprietary Name: | Ifosfamide |
Active Ingredient(s): | 50 mg/mL & nbsp; Ifosfamide |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-4495 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA201689 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121127 |
Package NDC: | 0069-4495-22 |
Package Description: | 20 mL in 1 VIAL (0069-4495-22) |
NDC Code | 0069-4495-22 |
Proprietary Name | Ifosfamide |
Package Description | 20 mL in 1 VIAL (0069-4495-22) |
Product NDC | 0069-4495 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ifosfamide |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20121127 |
Marketing Category Name | ANDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc. |
Substance Name | IFOSFAMIDE |
Strength Number | 50 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |